TPC-026

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameTPC-026
Drug Alias NameTPC-026
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityInsulin ResistanceMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetra Pharm Technologies ApS
China Registration ClassN/A

Develop Information

Active CompaniesTetra Pharm Technologies ApS
Inactive CompaniesN/A
Active IndicationsObesityInsulin ResistanceMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A